Financhill
Back

MannKind 10K Form

Sell
45

MNKD
MannKind

Last Price:
7.44
Seasonality Move:
7.1%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive MNKD News And Ratings

See the #1 stock for the next 7 days that we like better than MNKD

MNKD Financial Statistics

Sales & Book Value

Annual Sales: $198.96M
Cash Flow: $861K
Price / Cash Flow: 118.56
Annual Sales: $-0.82
Price / Book: 0

Profitability

EPS (TTM): 0.05000
Net Income (TTM): $11.74M
Gross Margin: $136.19M
Return on Equity: 0%
Return on Assets: 2.89%

MannKind Earnings Forecast

Key MannKind Financial Ratios

  • The Gross Profit Margin over the past 19 years for MNKD is 68.45%.
  • The Selling, General & Administrative Expenses for MNKD have been equal to 47.40% of Gross Profit Margin.
  • The Research & Development expenses have been 15.72% of Revenue.
  • The Interest Expense is -210.76% of Operating Income.
  • The Net Earning history of MNKD is -6.00% of Total Revenues.
  • Per Share Earnings over the last 24 years have been positive in 15 years.

MannKind Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: MNKD
CUSIP: 56400P
Website: mannkindcorp.com

Debt

Debt-to-Equity Ratio: -1.01
Current Ratio: 4.07
Quick Ratio: 3.39

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 40.33

MNKD Technical Analysis vs Fundamental Analysis

Sell
45
MannKind (MNKD) is a Sell

Is MannKind a Buy or a Sell?

  • MannKind stock is rated a Sell
    The current MannKind [MNKD] share price is $7.26. The Score for MNKD is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.